Signatera™ Wins Fierce Life Sciences Innovation Award

January 3, 2022 News 0

/PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a leader in personalized genetic testing and diagnostics, today announced that its personalized molecular residual…